http://faegrebdc.com/rare-disease en-us Copyright 2000-16 FaegreBD Consulting. All Rights Reserved. http://blogs.law.harvard.edu/tech/rss 11/27/2016 8:39:26 PM Samantha N. Strong has joined FaegreBD Consulting as an advisor with the health and biosciences team in Washington, D.C. Strong brings a strong focus on government advocacy. Grounded in pragmatic choices and political implications, she combines... http://faegrebdc.com/samantha-strong-brings-bioethics-background-to-faegrebd-consulting 31 May 2016 00:00:00:000 Kelly M. Nickel has joined FaegreBD Consulting as an advisor with the health and biosciences team in Washington, D.C. Nickel brings a range of experience in health care and advocacy circles. Her diverse background in today’s complex government... http://faegrebdc.com/kelly-nickel-brings-diverse-background-to-health-and-biosciences-team 20 Mar 2016 00:00:00:000 Bruce Quinn of FaegreBD Consulting will be the opening speaker at the Integrating Personalized Medicine Into Health Care Summit on October 14, 2015, at the Renaissance Hotel in Washington, D.C. His presentation will address “Meeting the Challenges... http://faegrebdc.com/integrating-personalized-medicine-into-health-care 14 Oct 2015 00:00:00:000 Lauren K. Bloch has joined FaegreBD Consulting as an advisor with the firm’s health and biosciences team in Washington, D.C., following multiple positions as a management consultant and project manager at the U.S. Departments of Health and Human... http://faegrebdc.com/lauren-bloch-brings-coalition-project-management-to-health-biosciences-team 24 Sep 2015 00:00:00:000 Bruce Quinn, M.D., Ph.D., has joined FaegreBD Consulting as a senior director with the firm’s health and biosciences team in Washington, D.C., where he leads the firm’s health markets and reimbursement strategy consulting practice. He has offices in... http://faegrebdc.com/health-markets-reimbursement-policy-expert-bruce-quinn-md-phd-joins 20 Jul 2015 00:00:00:000 A boost for authorized funding for the National Institutes of Health (NIH), a new $10 billion innovation fund at NIH and a paring back of many drug development incentives are among the many changes unveiled in the second draft of the 21st Century... http://faegrebdc.com/more-funding-less-drug-development-incentives-unveiled-in-21st-century 30 Apr 2015 00:00:00:000 The U.S. House Energy & Commerce Committee on January 27, 2015, released its much-anticipated 21st Century Cures discussion draft. The nearly 400-page bill includes more than 100 provisions across five titles and focuses significantly on reforms... http://faegrebdc.com/long-awaited-21st-century-cures-draft-released-what-does-the 28 Jan 2015 00:00:00:000 RDLA is a collaborative organization designed to support the advocacy of all rare disease groups. Nick Manetto, director in the health and biosciences team of FaegreBD Consulting, will speak at the RDLA October Meeting. He will provide insight on... http://faegrebdc.com/rare-disease-legislative-advocates-october-meeting 16 Oct 2014 00:00:00:000 Debra Lappin, principal at FaegreBD Consulting and president of the Council for American Medical Innovation, will moderate the first panel discussion, "Exploring New Avenues to Accelerate Research," during the 11th annual Indiana Life Sciences... http://faegrebdc.com/indiana-life-sciences-summit 15 Oct 2014 00:00:00:000 Patient advocates in Washington have faced tough times over the past few years. Tight federal budgets and limits on legislation for specific conditions have been frustrating for patient advocates, but signs indicate that change is coming as... http://faegrebdc.com/are-brighter-days-ahead-for-patient-advocates-in-washington 18 Sep 2014 00:00:00:000 As shock about the primary election defeat of House Majority Leader Eric Cantor abates and eyes turn to upcoming leadership races, questions remain as to the impact the loss will have on multiple issues, including medical innovation and biomedical... http://faegrebdc.com/house-leadership-transitions-21st-century-cures-and-the-medical-research 18 Jun 2014 00:00:00:000 On April 30, 2014, House Energy and Commerce Committee Chairman Fred Upton (R-MI) and Committee Member Diana DeGette (D-CO) announced the launch of 21st Century Cures, a new bipartisan initiative that aims to accelerate the pace of cures and medical... http://faegrebdc.com/opportunities-for-health-industry-following-21st-century-cures-initiative-launch 01 May 2014 00:00:00:000 Allison E. Durham has joined FaegreBD Consulting as a public policy specialist in the health and biosciences practice group in the firm's Washington, D.C. office. Prior to joining FaegreBD Consulting, Durham earned a Master of Science degree from... http://faegrebdc.com/allison-durham-joins-health-biosciences-group-at-faegrebd-consulting 31 Oct 2012 00:00:00:000 Debra R. Lappin of FaegreBD Consulting will serve as an expert consultant at the fourth annual Partnering for Cures meeting on Nov. 28-30, 2012, in New York City. The conference convenes sectors of the medical research industry and seeks to... http://faegrebdc.com/debra-lappin-to-consult-on-strategic-planning-at-national-medical 23 Oct 2012 00:00:00:000 Earlier in the week of September 24th, the Food and Drug Administration (FDA) posted Federal Register notices to implement two provisions of the recently enacted user fee law that seeks to enhance the role of the patient voice in the therapy... http://faegrebdc.com/fda-moving-forward-with-key-patient-engagement-provisions-in-user 01 Oct 2012 00:00:00:000